Private Equity Acquiring Large Shares Of The Opioid Treatment Market Without Changing Market-Level Methadone Supply
Using a difference-in-differences design with novel data on private equity acquisitions of opioid treatment programs and methadone shipments during the period 2006-19, this study examined the effects of PE acquisitions on methadone supply.